Working...
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 1 of 1 for:    INT230-6
Previous Study | Return to List | Next Study

A Phase 1/2 Safety Study of Intratumorally Dosed INT230-6 (IT-01)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT03058289
Recruitment Status : Recruiting
First Posted : February 20, 2017
Last Update Posted : November 21, 2018
Sponsor:
Collaborators:
University of Southern California
University Health Network, Toronto
Information provided by (Responsible Party):
Intensity Therapeutics, Inc.

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Recruiting
  Estimated Primary Completion Date : July 2019
  Estimated Study Completion Date : August 2020